Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging. Int J Radiat Oncol Biol Phys. 2012;84(3):762-767.Dorth,J.A.,Prosnitz,L.R.,Broadwater,G.,Diehl,L.F.,Beaven,A.W.,Coleman,R.E.,Kelsey,C.R.. ...
Relapse in stage I(E) diffuse large B‐cell lymphomaRelapse in stage I(E) diffuse large B‐cell lymphomaCNSdiffuse large B‐cell lymphomalimited stageMYCrelapsesurvivalDespite a general favourable outcome in limited stage diffuse large B-cell lymphoma (DLBCL), relapses occur in about 10 to 20...
Introduction: Diffuse large B‐cell lymphoma (DLBCL) presents as stage I in 15‐20% of patients and with extranodal (EN) involvement in 50%. Based on recent studies, 4 cycles of immunochemotherapy may be an option for low‐risk risk patients with negative interim PET/CT. However, the ...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma and the most common lymphoid neoplasm in adults (1). During recent decades, as chemotherapy has evolved, combination chemotherapy has become established as a standard treatment, but the role of radiation therapy ...
Objective To investigate the efficacy and safety of R-CHOP regimen( rituximab,cyclophosphamide,epirubicin,vincristine,prednisolone) for elderly patients with stage Ⅲ～Ⅳ diffuse large B-cell lymphoma( DLBCL).Methods Thirty-three patients aged ≥60 y diagnosed as stage Ⅲ～Ⅳ DLBCL were recruited cons...
Off Label Use: Iodine-131 tositumomab for large cell lymphoma. Gopal: GlaxoSmithKline: Research Funding. Press: Trubion Pharmaceuticals: Consultancy, Equity Ownership; PhaseRx: Equity Ownership; Algeta: Membership on an entity's Board of Directors or advisory committees; Celgene: Honoraria; Genentech...
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Ann Hematol. 2008;87(4):277–83. https://doi.org/10.1007/s00277-007-0399-y. 26. Berardi R, Torniai M, Pusceddu S, Spada F, Ibrahim T, ...
③The New England Journal of Medicine:Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma 复发性弥漫性大B细胞淋巴瘤的联合靶向治疗 DOI: 10.1056/NEJMoa2401532 ④The New England Journal of Medicine:Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma ...
Is stage 3 non-Hodgkin lymphoma curable? What is stage 2 esophageal cancer? What is diffuse large B-cell lymphoma? What stage of cervical cancer is terminal? What grade is diffuse large B-cell lymphoma? What is stage 4 thyroid cancer? What is stage 3 lung cancer? What is stage 5 lung...
During a Case-Based Roundtable® event, Christopher Maisel, MD, discussed third- and fourth-line therapy and barriers to bispecific therapy use in diffuse large B-cell lymphoma in the second article of a 2-part series. Read More From ABVD to Nivolumab-AVD: New Treatment Strategies in Hodgki...